Adc Therapeutics Sa Share Price: ADCT (Adc Therapeutics Sa) Stock Price Today & Updates | INDmoney

Question 1

What is Adc Therapeutics Sa share price today?

Accepted Answer

Adc Therapeutics Sa (ADCT) share price today is {{live_price}}.

Question 2

Can Indians buy Adc Therapeutics Sa shares?

Accepted Answer

Yes, Indians can invest in the Adc Therapeutics Sa (ADCT) from India.

With INDmoney, you can buy Adc Therapeutics Sa at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Adc Therapeutics Sa at zero transaction cost.

Question 3

How can I buy Adc Therapeutics Sa shares from India?

Accepted Answer

It is very easy to buy Adc Therapeutics Sa from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Question 4

Can Fractional shares of Adc Therapeutics Sa be purchased?

Accepted Answer

Yes, you can buy fractional shares of Adc Therapeutics Sa with INDmoney app.

Question 5

What are the documents required to start investing in Adc Therapeutics Sa stocks?

Accepted Answer

To start investing in Adc Therapeutics Sa, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

Question 6

What are today’s High and Low prices of Adc Therapeutics Sa

Accepted Answer

Today’s highest price of Adc Therapeutics Sa (ADCT) is {{1_rba_end}}.

Today’s lowest price of Adc Therapeutics Sa (ADCT) is {{1_rba_st}}.

Question 7

What is today's market capitalisation of Adc Therapeutics Sa

Accepted Answer

Today's market capitalisation of Adc Therapeutics Sa ADCT is 98.4M

Question 8

What is the 52 Week High and Low Range of Adc Therapeutics Sa

Accepted Answer

52 Week High
{{rba_end}}
52 Week Low
{{rba_st}}

Question 9

How much percentage Adc Therapeutics Sa is down from its 52 Week High?

Accepted Answer

Adc Therapeutics Sa (ADCT) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

Question 10

How much percentage Adc Therapeutics Sa is up from its 52 Week low?

Accepted Answer

Adc Therapeutics Sa (ADCT) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

Question 11

What are the historical returns of Adc Therapeutics Sa?

Accepted Answer

1 Month Returns
{{1mr}}%
3 Months Returns
{{3mr}}%
1 Year Returns
{{1yr}}%
5 Years Returns
{{5yr}}%

Question 12

Who is the Chief Executive Officer (CEO) of Adc Therapeutics Sa

Accepted Answer

Dr. Ameet  Mallik M.B.A., M.S. is the current Chief Executive Officer (CEO) of Adc Therapeutics Sa.

Period	Adc Therapeutics Sa	Sector (Health Care)	Index (Russel 2000)
3 Months	-64.0%	-1.4%	0.0%
6 Months	-63.64%	2.2%	2.0%
1 Year	-84.55%	6.0%	5.3%
3 Years	-97.86%	26.3%	19.9%

Market Capitalization	98.4M
Book Value	- $0.1
Dividend Share	0.0
Dividend Yield	0.0%
Earnings Per Share (EPS)	-2.31
Wall Street Target Price	8.17

Profit Margin	-98.33%
Operating Margin TTM	-56.94%

Return On Assets TTM	-12.77%
Return On Equity TTM	-339.67%

Revenue TTM	184.4M
Revenue Per Share TTM	2.3
Quarterly Revenue Growth YOY	11.5%
Gross Profit TTM	35.1M
EBITDA	-103.9M
Diluted Eps TTM	-2.31
Quarterly Earnings Growth YOY	0.0

Adc Therapeutics Sa (ADCT)

Insights on Adc Therapeutics Sa

Increasing Revenue

Increasing Net Profit

Vs NVO

Vs NVO

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Technicals Summary

Peers

Institutional Holdings

Corporate Announcements

Adc Therapeutics Sa Earnings

Company Information

Discover More

FAQs

EPS Estimate Current Year	-1.9
EPS Estimate Next Year	-2.61
EPS Estimate Current Quarter	-0.46
EPS Estimate Next Quarter	-0.7

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Adc Therapeutics Sa	-44.19%	-63.64%	-84.55%	-97.86%	-97.57%
Moderna, Inc.	-10.67%	-32.6%	-16.46%	43.93%	437.58%
Regeneron Pharmaceuticals, Inc.	-0.66%	0.54%	20.22%	43.69%	111.47%
Novo Nordisk A/s	2.15%	146.19%	299.73%	451.49%	690.33%
Seagen, Inc.	6.95%	7.06%	57.98%	15.54%	167.56%
Vertex Pharmaceuticals Incorporated	-0.15%	13.31%	26.28%	30.33%	91.37%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Adc Therapeutics Sa	NA	NA	NA	-1.9	-3.4	-0.13	0.0	-0.1
Moderna, Inc.	34.92	34.92	0.0	-3.42	0.07	0.01	0.0	44.49
Regeneron Pharmaceuticals, Inc.	21.9	21.9	9.01	41.82	0.19	0.1	0.0	225.94
Novo Nordisk A/s	42.86	42.86	2.03	1.66	0.82	0.22	0.01	2.52
Seagen, Inc.	NA	NA	18.53	-3.52	-0.26	-0.13	0.0	13.96
Vertex Pharmaceuticals Incorporated	27.48	27.48	0.41	14.71	0.25	0.16	0.0	60.01

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Adc Therapeutics Sa	Buy	$98.4M	-97.57%	NA	-98.33%
Moderna, Inc.	Buy	$38.1B	437.58%	34.92	11.33%
Regeneron Pharmaceuticals, Inc.	Buy	$89.4B	111.47%	21.9	33.93%
Novo Nordisk A/s	Buy	$409.3B	690.33%	42.86	33.4%
Seagen, Inc.	Hold	$38.7B	167.56%	NA	-33.55%
Vertex Pharmaceuticals Incorporated	Buy	$90.2B	91.37%	27.48	35.4%

Organization	Adc Therapeutics Sa
Employees	317
CEO	Dr. Ameet Mallik M.B.A., M.S.
Industry	Health Technology